1. 3074 Platinum-pemetrexed palliative chemotherapy in malignant pleural mesothelioma from Spanish BEMME database The Spanish Lung Cancer Group (SLCG). (September 2015) Authors: Remon, J.; Reguart, N.; Garcia, Y.; Nadal, E.; Lopez-castro, R.; Garcia-campelo, R.; Martin-martorell, P.; Juan, O.; Olmedo, E.; Trancho, F.; Domine, M.; Ponce, S.; Cumplido, D.; Majem, M.; Massuti, B.; Porta, R.; Rodriguez-abreu, D.; Provencio, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S622 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3081 Molecular Tumor Board (MTB) in non-small cell lung cancers (NSCLC) to optimize targeted therapies: 4 years' experience at Gustave Roussy. (September 2015) Authors: Planchard, D.; Faivre, L.; Sullivan, I.; Kahn-charpy, V.; Lacroix, L.; Auger, N.; Adam, J.; De Montpreville, V. Thomas; Dorfmuller, P.; Pechoux, C. Le; Chevalier, T. Le; Gazzah, A.; Remon, J.; Bescher, G.; Soria, J.C.; Pignon, J.P.; Besse, B. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S624 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Activity and safety of oral etoposide in pretreated patients with metastatic or recurrent thymic epithelial tumors (TET): A single-institution experience. (September 2016) Authors: Bluthgen, M.V.; Boutros, C.; Fayard, F.; Remon, J.; Planchard, D.; Besse, B. Journal: Lung cancer Issue: Volume 99(2016) Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMA. (May 2022) Authors: Remon, Jordi; Lacas, Benjamin; Herbst, Roy; Reck, Martin; Garon, Edward B.; Scagliotti, Giorgio V.; Ramlau, Rodryg; Hanna, Nasser; Vansteenkiste, Johan; Yoh, Kiyotaka; Groen, Harry J.M.; Heymach, John V.; Mandrekar, Sumithra J.; Okamoto, Isamu; Neal, Joel W.; Heist, Rebecca S.; Planchard, David; ... Journal: European journal of cancer Issue: Volume 166(2022) Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CD52, CD22, CD26, EG5 and IGF-1R expression in thymic malignancies. (June 2017) Authors: Remon, J.; Abedallaa, N.; Taranchon-Clermont, E.; Bluthgen, V.; Lindsay, C.R.; Besse, B.; Thomas de Montpréville, V. Journal: Lung cancer Issue: Volume 108(2017) Page Start: 168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Circulating innate immune markers and outcomes in treatment-naïve advanced non–small cell lung cancer patients. (February 2019) Authors: Charrier, M.; Mezquita, L.; Lueza, B.; Dupraz, L.; Planchard, D.; Remon, J.; Caramella, C.; Cassard, L.; Boselli, L.; Reiners, K.S.; Pogge von Strandmann, E.; Rusakiewicz, S.; Ferrara, R.; Duchemann, B.; Naigeon, M.; Pignon, J.P.; Besse, B.; Chaput, N. Journal: European journal of cancer Issue: Volume 108(2019) Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Corrigendum to "Immune-checkpoint inhibition in first-line treatment of advanced non-small cell lung cancer patients: Current status and future approaches" [Lung Cancer 106 (2017) 70–75]. (March 2018) Authors: Remon, J.; Pardo, N.; Martinez-Martí, A.; Cedrés, S.; Navarro, A.; Martinez de Castro, A.M.; Felip, E. Journal: Lung cancer Issue: Volume 117(2018) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Immune checkpoint inhibitors in non-small cell lung cancer (NSCLC): Approaches on special subgroups and unresolved burning questions. (March 2018) Authors: Remon, J.; Vilariño, N.; Reguart, N. Journal: Cancer treatment reviews Issue: Volume 64(2018) Page Start: 21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Immune-checkpoint inhibition in first-line treatment of advanced non-small cell lung cancer patients: Current status and future approaches. (April 2017) Authors: Remon, J.; Pardo, N.; Martinez-Martí, A.; Cedrés, S.; Navarro, A.; Martinez de Castro, A.M.; Felip, E. Journal: Lung cancer Issue: Volume 106(2017) Page Start: 70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Immunotherapy for oncogenic-driven advanced non-small cell lung cancers: Is the time ripe for a change?. (December 2018) Authors: Remon, J.; Hendriks, L.E.; Cabrera, C.; Reguart, N.; Besse, B. Journal: Cancer treatment reviews Issue: Volume 71(2018) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗